Rocket Pharmaceuticals in-27RCKTWPreferred / convertible
13F holders, Q4 2024 (December 31)10holders −4
1new positions
5sold out
1famous investor
$0.25avg. 13F price*
At the end of Q4 2024, 10 institutions reported holding Rocket Pharmaceuticals in-27 (RCKTW) in their 13F filings, down 4 from Q3 2024. 1 opened new positions and 5 sold out. The largest holders were Boothbay Fund Management, LLC ($464K), Walleye Capital LLC ($23K) and Sio Capital Management, LLC ($15K). One famous investor held it Ken Griffin ( of Citadel Advisors's portfolio).
- Company
- Rocket Pharmaceuticals in-27
- CUSIP
- 77313F114
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $3K |
| Exits | 5 | $81K |
All 13F filers, Q3 2024 → Q4 2024: 124,893 shares bought and 1,206,361 shares sold, net −1,081,468 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 10 holders
| Boothbay Fund Management, LLC | — | No change | 36,912 | $464K |
| Walleye Capital LLC | — | Reduce -6.8% | 671,743 | $23K |
| Sio Capital Management, LLC | — | No change | 400,000 | $15K |
| RTW Investments, LP | — | No change | 350,000 | $12K |
| Citadel Advisors | — | Reduce -1.7% | 337,604 | $12K |
| Silverarc Capital Management, LLC | — | No change | 104,828 | $4K |
| Walleye Trading LLC | — | Add +141.2% | 83,991 | $3K |
| LMR Partners LLP | — | New | 75,731 | $3K |
| Affinity Asset Advisors, LLC | — | No change | 75,000 | $3K |
| Ancora Advisors LLC | — | No change | 6,000 | $206 |
"% of holder's portfolio" is RCKTW's weight in each manager's 13F, not the share of Rocket Pharmaceuticals in-27 the manager owns.